Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study.
- Author:
Yeshi METAFERIA
1
;
Walelign DESSIE
;
Ibrahim ALI
;
Anteneh AMSALU
Author Information
- Publication Type:Original Article
- Keywords: Hepatitis B virus; Pregnant women; Enzyme-linked immunosorbent assay; Ethiopia
- MeSH: Cross-Sectional Studies*; Education; Enzyme-Linked Immunosorbent Assay; Ethiopia*; Female; Hepatitis B Surface Antigens; Hepatitis B virus*; Hepatitis B*; Hepatitis*; HIV; Humans; Mass Screening; Pregnant Women*; Prevalence; Public Health; Referral and Consultation; Risk Factors*; Seroepidemiologic Studies*
- From:Epidemiology and Health 2016;38(1):e2016027-
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: Hepatitis B virus (HBV) is a major blood-borne and sexually transmitted infectious agent that is a significant global public health issue. The aim of this study was to determine the seroprevalence and risk factors of HBV among pregnant women attending the antenatal clinic of the Hawassa University referral hospital in Ethiopia. METHODS: A cross-sectional study was conducted from April to May, 2015. A total of 269 consecutive pregnant women attending antenatal consultations were enrolled. Sociodemographic information and data regarding possible risk factors were collected using a structured questionnaire. Hepatitis B surface antigen (HBsAg) screening was performed using an enzyme-linked immunosorbent assay, and the data were analyzed. RESULTS: The overall seroprevalence of HBsAg among the 269 participants enrolled in the study was 7.8% (n=21). The prevalence of human immunodeficiency virus (HIV) infection was 5.2% (n=14), of whom two participants (14.2%) were also positive for HBsAg. Study participants with no formal education (odds ratio [OR], 3.68; 95% confidence interval [CI], 1.27 to 10.68; p<0.05) were more likely to be infected with HBV than those who had completed at least secondary school. Although HBsAg was detected more often in pregnant women who had multiple exposure factors (8.8%, n=13) than in pregnant women who had not experienced possible risk factors (4%, n=1), this difference was not statistically significant (OR, 2.33; 95%CI, 0.29 to 18.63). CONCLUSIONS: A high prevalence of HBV infection was detected in the study population. Neither the type of risk factors nor exposure to multiple risk factors was significantly associated with HBV infection. Hence, screening pregnant women regardless of risk factors and improving awareness of the transmission routes of HBV within this group may reduce the risk of HBV infections.
